A new research study has shown that pancreatic cancer cells can be coaxed to revert back toward normal cells by introducing a protein called E47.
E47 binds to specific DNA sequences and controls genes involved in growth and differentiation. The research provides hope for a new treatment approach for the more than 40,000 people who die from the disease each year in the United States.
“For the first time, we have shown that overexpression of a single gene can reduce the tumor-promoting potential of pancreatic adenocarcinoma cells and reprogram them toward their original cell type. Thus, pancreatic cancer cells retain a genetic memory which we hope to exploit,” said Pamela Itkin-Ansari, Ph.D., adjunct professor in the Development, Aging, and Regeneration Program at Sanford-Burnham and lead author of the study published today in the journal Pancreas.
E47 turns the clock back
The study, a collaborative effort between Sanford-Burnham, UC San Diego, where Itkin-Ansari holds a joint appointment, and Purdue University, generated human pancreatic ductal adenocarcinoma cell lines to make higher-than-normal levels of E47. The increased amount of E47 caused cells to stall in the G0/G1 growth phase, and differentiate back toward an acinar cell phenotype.
In-vivo studies showed that when the reprogrammed cancer cells were introduced into mice, their ability to form tumors was greatly diminished compared to untreated adenocarcinoma cells.
“Presently, pancreatic adenocarcinoma is treated with cytotoxic agents, yet the average survival for patients post-diagnosis is merely six months, and the improvements in therapies are measured in days,” said Andrew M. Lowy, M.D., professor of surgery at the UC San Diego Moores Cancer Center and co-chair of the National Cancer Institute’s Pancreatic Cancer Task Force. “The finding that we can differentiate these cancer cells back to a non-threatening phenotype is encouraging. Indeed, there is a precedent for cell differentiation therapy in that the approach has been used to treat acute promyelocytic leukemia (APL) and some neuroblastomas successfully.”
“Our next step is to test primary patient-derived tumor tissue to determine whether E47 can produce similar results, potentially providing a novel therapeutic approach to combating this highly lethal disease,” said Itkin-Ansari. “Additionally, we are screening for molecules—potential drugs—that can induce overexpression of E47.”
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Alex Trebek, who is battling pancreatic cancer, sends ‘Jeopardy!’ fans a hopeful message on April 17, 2019 at 4:07 pm
Alex Trebek signed off following the final day of taping for the 35th year of “Jeopardy!”, and he told fans of the popular game show that he planned to return later this year for another season of ... […]
- ‘Jeopardy’ host Alex Trebek plans to return in September, despite cancer diagnosis on April 17, 2019 at 3:58 pm
“Jeopardy” is readying for its summer break, but longtime host Alex Trebek, who is battling pancreatic cancer, said he looks forward to returning to the popular TV game show September. “I look forward ... […]
- Alex Trebek reassures 'Jeopardy!' fans about his health during cancer treatment: 'I'm feeling good' on April 17, 2019 at 3:42 pm
The 78-year-old, who has been the face of the show since 1984, said in a video shared on social media that he’s “feeling good” as he undergoes treatment for stage IV pancreatic cancer. He noted that ... […]
- Dr. Tempero on Role of Molecular Profiling in Pancreatic Cancer on April 17, 2019 at 3:02 pm
Margaret A. Tempero, MD, director, University of California, San Francisco (UCSF) Pancreas Center, professor of medicine, Division of Hematology and Oncology, Rombauer Family Distinguished Professor ... […]
- WATCH: ‘Jeopardy’ host Alex Trebek gives update on his progress after pancreatic cancer diagnosis. ‘I’m touched beyond words.’ on April 17, 2019 at 2:46 pm
When Alex Trebek announced in March that he had been diagnosed with stage 4 pancreatic cancer, “Jeopardy!" fans rallied to support him. Trebek vowed to stay on the job, even as he sought treatment — ... […]
- 'Mami's Message' to raise money for pancreatic cancer research on April 17, 2019 at 11:34 am
Natalia Piferrer and her mother used to spend every birthday going out to dinner and making wishes on candles. This year, Piferrer will spend her mother’s birthday making with another wish: to raise ... […]
- Key protein a possible new target in the treatment of pancreatic cancer on April 17, 2019 at 10:21 am
WOODBURY, N.Y., April 17, 2019 -- Pancreatic cancer can be difficult to treat and often responds poorly to chemotherapy due to the presence of tumor cells located within the dense protective tissue, ... […]
- New study targets Achilles' heel of pancreatic cancer, with promising results on April 17, 2019 at 10:02 am
Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread throughout the body. Additionally, tumor cells are encased in a "protective shield," a ... […]
- Achilles’ heel of pancreatic cancer may lead to improved patient treatment on April 17, 2019 at 9:46 am
Scientists may have discovered the “Achilles’ heel” of pancreatic cancer – a condition which is notoriously difficult to treat. Researchers believe a protein called leukaemia inhibitory factor (LIF) ... […]
- Neoadjuvant Strategy Improves Survival in Pancreatic Cancer Resection on April 15, 2019 at 12:42 pm
Researchers sought to identify predictive factors associated with morbidity, mortality, and survival outcomes in patients with BR or LA PDAC who undergo TNT prior to surgical resection. Pancreatic ... […]
via Bing News